Roche Pulls Two Phase II Covid-19 StudiesClinical Trials, Coronavirus Disease (COVID-19) Pandemic, Covid-19 Pneumonia, Financials, IL-22 inhibitors, Monoclonal Antibodies, Quarterly results, R&D, RocheRoche culled two more Phase II Covid-19 programs, as announced in the Swiss pharma giant’s first-quarter 2021 financial report. Read more April 21, 2021/by Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2021/04/Roche-Quietly-Pulls-Two-Phase-II-COVID-19-Studies-in-Q1-BioSpace-4-21-21.jpeg 350 625 Andrew Humphreys https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Andrew Humphreys2021-04-21 17:48:572021-04-21 17:51:51Roche Pulls Two Phase II Covid-19 Studies